Table 1.

Demographic details and laboratory findings of SARS-CoV-2-infected hospitalized asymptomatic patients.

Characteristics	Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6
Age	47	70	29	51	40	29
Sex	M	M	M	M	M	M
Symptoms	Asy	Asy	Asy	Asy	Asy	Asy
Comorbidities	None	NA	None	NA	None	None
Travel history	Delhi	NA	Bangalore	None	Hyderabad	Hyderabad
Medication	Pantoprazole, azithromycin, ascorbic acid, and ivermectin	Pantoprazole, azithromycin, ascorbic acid, and ivermectin	Pantoprazole, azithromycin, ascorbic acid, and ivermectin	Pantoprazole, azithromycin, ascorbic acid, and ivermectin	Pantoprazole, azithromycin, ascorbic acid, and ivermectin	Pantoprazole, azithromycin, ascorbic acid, and ivermectin
Duration of stay in hospital	11 days	11 days	10 days	11 days	10 days	11 days
WBC count, 103 cells per µl	3.9	5.9	5.8	05	8.7	5.8
Neutrophils, differential count (%)	43	43	50	66	71	55
Lymphocytes, differential count (%)	46	45	38	15	17	36
Monocytes, differential count (%)	08	09	09	13	09	07
Eosinophils, differential count (%)	03	03	03	06	03	02
Basophils, differential count (%)	0	0	0	0	0	0
RBC count, 106 per µl	3.7	5.95	4.96	5.46	5.43	5.76
Hemoglobin, g/dl	10.4	13.6	15	14.5	14	17.4
MCV, fl/µm3	88.1	71.4	88.7	80.2	78.8	88.4
Platelet count, 103 per µl	155	250	211	165	93	164
Ferritin, ng/ml	115	492	361	115	57	218
Serum bilirubin total, mg per dl	0.12	0.45	1.2	0.42	0.5	0.92
Serum SGOT, U/L	30	59	38	38	26	45
Serum SGPT, U/L	23	142	39	48	19	42
Serum alkaline phosphatase, U/L	48	91	89	64	94	127
Serum albumin, g/L	4.0	4.6	4.6	3.9	4.1	5
Serum globulin, g/L	2.7	2.7	2.5	2.3	2.4	2.7
Status of the patients	Recovered	Recovered	Recovered	Recovered	Recovered	Recovered

Asy, asymptomatic; NA, not available.